SC 13D Filing

Company

PharmaCyte Biotech, Inc.

Filed

November 4, 2021

Accession Number

0000930413-21-001835

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →